Skip to main content
Account
Fig. 9 | Nanoscale Research Letters

Fig. 9

From: Anti-Epcam Aptamer (Syl3c)-Functionalized Liposome for Targeted Delivery Of Doxorubicin: In Vitro And In Vivo Antitumor Studies in Mice Bearing C26 Colon Carcinoma

Fig. 9

In vivo therapeutic efficacy of formulations in female BALB/c mice bearing C26 colon carcinoma. Mice received IV injection of single dose of formulations (10 mg/kg). a Represents the respective weight percentage profile of the BALB/c in each experimental group. b Depicts the tumor size follow-ups in BALB/c mice. c Shows the survival graph for BALB/c. Data represented as mean ± SD (n = 5)

Back to article page

Navigation